AbCellera Biologics, Inc. (ABCL)
5.20
+0.06
(+1.17%)
USD |
NASDAQ |
May 22, 16:00
5.26
+0.06
(+1.15%)
After-Hours: 20:00
AbCellera Biologics Shareholders Equity (Quarterly) : 938.08M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Tempus AI, Inc. | 416.40M |
| Standard BioTools, Inc. | 561.12M |
| Cytek Biosciences, Inc. | 327.64M |
| Agilent Technologies, Inc. | 6.908B |
| Inotiv, Inc. | 77.10M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.307B |
| Total Liabilities (Quarterly) | 192.92M |
| Debt to Equity Ratio | 0.1494 |
| Current Ratio | 14.05 |
| Net Debt Paydown Yield | -1.41% |